ACIP Live Meeting Archive – October 2020
Meeting Agenda October 28 – 30, 2020 [3 pages]
Video of ACIP meetings is now posted to the CDC Streaming Health channel* on YouTube. View the specific ACIP channel on YouTube or view specific links below. Controls for video volume, pause, and rewind appear along the bottom of the display.
Videos: October 28, 2020
Welcome & Immunization Schedules [75 minutes]
Welcome & Introductions; Introduction to combined immunization schedule work group; Proposed changes to 2021 child/adolescent immunization
schedule; Proposed changes to 2021 adult immunization schedule
Seasonal Influenza Vaccines [73 minutes]
Introduction; Efficacy of cell-derived quadrivalent influenza vaccine (Flucelvax Quadrivalent) in children & adolescents ≥2 years to <18 years old; Influenza Disease Burden and Vaccine Impact Estimates, 2019-20 Season; End-of-Season Estimates of 2019–20 Seasonal Influenza Vaccine; Effectiveness against Medically Attended Influenza from three
U.S. Networks; Updates and WG Considerations
Orthopoxvirus Vaccine [95 minutes]
Introduction; Orthopoxvirus work group background; JYNNEOS® (MVA-BN®) Smallpox and Monkeypox Vaccine; Variola virus plaque reduction neutralization assay for the
Vaccinating against monkeypox in the Democratic Republic of the Congo with JYNNEOS®
Dengue Vaccines [89 minutes]
Introduction; Pneumococcal Vaccines; Work group introduction
Videos: October 29, 2020
Cholera Vaccine; Vote; Zoster Vaccine [111 minutes]
Introduction; Pneumococcal Vaccines; Work group introduction; Update on post-licensure safety monitoring of recombinant zoster vaccine (RZV, Shingrix) in the Vaccine Adverse Event; Reporting System (VAERS); Vaccine Safety Datalink (VSD) update on post-licensure safety monitoring of RZV; Risk of Guillain-Barré syndrome following herpes zoster
Summary and planned risk-benefit analysis regarding use of RZV in immunocompetent adults; Planned risk-benefit analysis regarding use of RZV in immunocompetent adults
Tick-borne Encephalitis Vaccine [54 minutes]
Overview of tick-borne encephalitis (TBE) and TBE vaccine; Immunogenicity and safety of Pfizer’s TBE vaccine; Next steps for TBE vaccine work group
Rabies Vaccine [72 minutes]
Introduction; Minimum acceptable rabies antibody titer and implications on ACIP recommendations; Pertinent fundamentals of rabies immunology
Pre-exposure prophylaxis [83 minutes]
Pre-exposure prophylaxis schedule: Grading of recommendations assessment, development, and evaluation (GRADE); Evidence to recommendation framework (EtR);
Summary and next steps
Videos: October 30, 2020
Coronavirus Disease 2019 (COVID-19) Vaccines (video1) [126 minutes] ; Coronavirus Disease 2019 (COVID-19) Vaccines (video2) [54 minutes]
Introduction; Update from Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting; NVX-CoV2373 Vaccine Candidate; Janssen’s SARS-CoV-2 Vaccine Program
Post-authorization safety monitoring [110 minutes]
FDA safety surveillance systems; Post-authorization safety monitoring plans; Modeling strategies for the initial allocation of COVID-19 vaccines Discussion
Updates to immunity and epidemiology [113 minutes]
Updates to immunity and epidemiology to inform COVID-19; Ethical principles for early vaccine allocation; Work Group interpretation of data; Policy questions, Evidence to Recommendation Framework, and Discussion
*The CDC Streaming Health channel on YouTube hosts more than 600 videos on a variety of health topics. YouTube’s design allows viewing on mobile devices, tablets, desktops, and laptops.